# EDGAR Filing Document

**Accession Number:** 0001756655
**File Stem:** 0001628280-25-042486
**Filing Date:** 2025-9
**Character Count:** 10926
**Document Hash:** 06f160b6af2bc8051323aa1c92ff055f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-042486.hdr.sgml**: 20250923

**ACCESSION NUMBER**: 0001628280-25-042486

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20250918

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250923

**DATE AS OF CHANGE**: 20250923

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Ardent Health, Inc.
- **CENTRAL INDEX KEY:** 0001756655
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 611764793
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42180
- **FILM NUMBER:** 251334029

**BUSINESS ADDRESS:**
- **STREET 1:** 340 SEVEN SPRINGS WAY
- **STREET 2:** SUITE 100
- **CITY:** BRENTWOOD
- **STATE:** TN
- **ZIP:** 37027
- **BUSINESS PHONE:** 6152963000

**MAIL ADDRESS:**
- **STREET 1:** 340 SEVEN SPRINGS WAY
- **STREET 2:** SUITE 100
- **CITY:** BRENTWOOD
- **STATE:** TN
- **ZIP:** 37027

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ardent Health Partners, Inc.
- **DATE OF NAME CHANGE:** 20240717

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ardent Health Partners, LLC
- **DATE OF NAME CHANGE:** 20181022

?xml version='1.0' encoding='ASCII'? ardt-20250918

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**<br>

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): September 23, 2025 (September 18, 2025)**

---

| | |
|:---|:---|
| **ARDENT HEALTH, INC.** | **ARDENT HEALTH, INC.** |
|  | **(Exact Name of Registrant as Specified in its Charter)** |

---

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-42180** | **61-1764793** |
| (State or Other Jurisdiction<br>of Incorporation)<br>| (Commission<br>File Number)<br>| (I.R.S. Employer<br>Identification No.)<br>|

---

---

| | |
|:---|:---|
| **340 Seven Springs Way, Suite 100,** <br>**Brentwood, Tennessee**<br>| **37027** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

**(615) 296-3000**

(Registrant's Telephone Number, including Area Code)

**Not Applicable**

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under

any of the following provisions:

□ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each Class** | **Trading**<br>**Symbol(s)**<br>| **Name of each exchange**<br>**on which registered**<br>|
| Common Stock, $.01 par value per share | ARDT | New York Stock Exchange |

---

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933

(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company □

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for

complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

**Item 1.01.Entry into a Material Definitive Agreement.**

On September 18, 2025 (the "Amendment Effective Date"), Ardent Health, Inc., a Delaware corporation (the "Company"),

AHP Health Partners, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (the "Borrower"),

certain wholly-owned subsidiaries of the Borrower party thereto (the "Subsidiary Guarantors"), Bank of America, N.A.

("Bank of America"), as administrative agent, and the other financial institutions party thereto entered into Amendment No.

3 (the "Term Loan Amendment"), which amends that certain Amended and Restated Term Loan Credit Agreement, dated

as of August 24, 2021, by and among the Borrower, the Company, the Subsidiary Guarantors, Bank of America and the

other financial institutions party thereto from time to time (as amended, the "Term Loan Credit Agreement"). Also, on

September 18, 2025, the Company, the Borrower, AHS East Texas Health System, LLC ("AHS East Texas"), certain

subsidiaries of the Borrower and AHS East Texas party thereto as borrowers, certain Subsidiary Guarantors, the lenders

party thereto and Bank of America, as administrative agent, entered into Amendment No. 5 to Amended and Restated ABL

Credit Agreement (the "ABL Amendment"), which amends that certain Amended and Restated ABL Credit Agreement,

dated as of July 8, 2021 (as amended, the "ABL Credit Agreement"), by and among the borrowers, guarantors and lenders

party thereto and Bank of America.

The Term Loan Amendment amended the Term Loan Credit Agreement to, among other things, (i) refinance in full all of

the outstanding term loans under the Term Loan Credit Agreement (as in effect immediately prior to the Term Loan

Amendment), (ii) extend the maturity date for the term loans from August 24, 2028 to September 18, 2032, (iii) reduce the

applicable interest rate by 50 basis points from Term Secured Overnight Financing Rate ("SOFR") plus 2.75% to Term

SOFR plus 2.25%, and from the base rate plus 1.75% to the base rate plus 1.25% and (iv) increase the baskets for certain

fixed dollar negative covenants.

The ABL Amendment amended the ABL Credit Agreement to update the baskets for certain fixed dollar negative

covenants to match the terms of the Term Loan Credit Agreement (as amended by the Term Loan Amendment), but it did

not extend the maturity date or make any material changes to the ABL Credit Agreement. The foregoing description of the

Term Loan Amendment is qualified in its entirety by the text of the Term Loan Amendment, which is filed as <u>Exhibit 10.1</u>

to this Current Report on Form 8-K and incorporated herein by reference. The foregoing description of the ABL

Amendment is qualified in its entirety by the text of the ABL Amendment, which is filed as <u>Exhibit 10.2</u> to this Current

Report on Form 8-K and incorporated herein by reference.

**Item 2.03.Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of** 

**a Registrant.**

The information set forth above under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference

into this Item 2.03.

**Item 9.01. Financial Statements and Exhibits.**

(d)Exhibits:

---

| | |
|:---|:---|
| **Exhibit No.** | **Exhibit Description** |
| 10.1 | <u>[Amendment No. 3 to Amended and Restated Term Loan Credit Agreement, dated as of September 18,](ex101-amendment3totermloan.htm)</u> <br><u>[2025, by and among AHP Health Partners, Inc., as Borrower, Ardent Health, Inc., the Guarantors, the](ex101-amendment3totermloan.htm)</u> <br><u>[Lenders and Bank of America, N.A., as the Additional 2025 Term B Lender and as Administrative Agent](ex101-amendment3totermloan.htm)</u><br>|
| 10.2 | <u>[Amendment No. 5 to Amended and Restated ABL Credit Agreement, dated as of September 18, 2025, by](ex102-amendment5toablcredi.htm)</u> <br><u>[and among AHP Health Partners, Inc., AHS East Texas Health System, LLC, Ardent Health, Inc., the](ex102-amendment5toablcredi.htm)</u> <br><u>[Subsidiaries of AHP Health Partners, Inc. and AHS East Texas Health System, LLC, as Borrowers, the](ex102-amendment5toablcredi.htm)</u> <br><u>[Guarantors, the Lenders, and Bank of America, N.A., as Administrative Agent](ex102-amendment5toablcredi.htm)</u><br>|
| 99 | <u>[Press release issued on September 22, 2025](ex99-pressrelease.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed

on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Dated: September 23, 2025 | **ARDENT HEALTH, INC.** | **ARDENT HEALTH, INC.** |
|  | By: | /s/ Stephen C. Petrovich |
|  | Name: | Stephen C. Petrovich |
|  | Title: | Executive Vice President & General Counsel |

---

## Ex-99

**EXHIBIT 99**

![ardtlogo.jpg](ardtlogo.jpg)

**Ardent Announces Successful Amendment and Extension of** 

**Term Loan Facility**

**BRENTWOOD, Tenn. (Sept. 22, 2025)** – Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized

urban communities across the U.S., today announced that it has successfully amended and extended its $777.5 million

Term Loan Facility. The new terms reduce the applicable interest rate by 50 basis points from Term Secured Overnight

Financing Rate (SOFR) plus 2.75% to Term SOFR plus 2.25%. The transaction extends the maturity of the facility to

September 2032.

"This transaction enhances our financial flexibility and strengthens our capital position, allowing Ardent to continue

investing in our communities while pursuing strategic growth," said Ardent Health Chief Financial Officer Alfred Lumsdaine.

"We appreciate the support of our lending partners and their continued confidence in our leadership and long-term growth

strategy."

The amended credit agreement is expected to reduce Ardent's interest expense by approximately $3.9 million annually.

###

**About Ardent Health** 

Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S.

With a focus on people and investments in innovative services and technologies, Ardent is passionate about making

healthcare better and easier to access. Through its subsidiaries, the Company delivers care through a system of 30 acute

care hospitals and approximately 280 sites of care with over 1,800 employed and affiliated providers across six states. For

more information, please visit ardenthealth.com.

**Investor Contact:**

Dave Styblo, CFA

SVP, Investor Relations

Ardent Health

Investor.Relations@ardenthealth.com

(615) 296-3016

**Media Contact:**

Rebecca Kirkham

SVP, Communications & Corporate Affairs

Ardent Health

rebecca.kirkham@ardenthealth.com

(615) 296-3000